Clinical Trial Update: Liraglutide to Improve corONary Haemodynamics During Exercise streSS [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating liraglutide to improve coronary haemodynamics during exercise in ischemic heart disease, coronary heart disease, and chronic sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease
• Ischemic Heart Disease
• Stable Angina

Drugs mentioned

• liraglutide (liraglutide)

Snippet

Sponsor: King's College London | Conditions: Ischaemic Heart Disease, Coronary Heart Disease | Phase 2 | Status: COMPLETED